Modification of biopharmaceutical parameters of flavonoids: a review
Amir Taldaev,
No information about this author
Artem A. Svotin,
No information about this author
Semyon I Obukhov
No information about this author
et al.
Frontiers in Chemistry,
Journal Year:
2025,
Volume and Issue:
13
Published: April 29, 2025
Flavonoids
are
natural
organic
compounds
that
derivatives
of
diphenylpropane.
This
group
polyphenols
can
be
found
in
multiple
sources
and
they
exhibit
a
variety
biological
effects.
Despite
the
wide
array
beneficial
properties,
development
drugs
based
on
these
is
hindered
by
their
low
bioavailability.
Although
substantial
body
information
available
strategies
to
enhance
solubility
bioavailability
flavonoids,
this
knowledge
remains
fragmented.
Therefore,
aim
study
was
consolidate
systematize
scientific
data
methods
for
increasing
flavonoid
without
changing
initial
molecular
structures.
Throughout
investigation,
it
determined
most
prevalent
include
co-crystallization,
formation
phospholipid
inclusion
complexes,
creation
nanostructures.
there
were
no
pronounced
differences
observed
enhancing
solubility,
impact
pharmacokinetic
parameters
established.
It
production
complexes
nanostructures
leads
greatest
increase
area
under
curve
an
average
4.2
3.7
times,
respectively.
The
least
effect
noted
phytosomes,
where
parameter
modified
forms
exceeded
value
only
1.7
times.
Phospholipid
exhibited
longer
half-elimination
time
than
all
other
modifications,
achieving
2.1-fold
increase.
For
micelles,
maximum
concentration
active
substance
blood
plasma
observed,
reaching
5.4
times
both
types
modifications.
During
systematization
generalization
data,
high
level
heterogeneity
assessment
across
various
studies
revealed,
complicating
comparisons
original
obtained
different
researchers.
findings
review
crucial
researchers
investigating
will
facilitate
selection
effective
desired
outcomes
Language: Английский
Evaluating the Potential of Herbal Extracts as Treatment in Immune Thrombocytopenia: A Review of Evidence and Limitations
Robert E. Wiggins,
No information about this author
Jonathan C. G. Woo,
No information about this author
John Nicholas Cauba
No information about this author
et al.
Applied Biosciences,
Journal Year:
2024,
Volume and Issue:
4(1), P. 1 - 1
Published: Dec. 27, 2024
Immune
thrombocytopenia,
formerly
idiopathic
thrombocytopenia
purpura
(ITP),
is
an
autoimmune
disease
characterized
by
the
depletion
of
platelets
below
100,000/µL
when
other
causes
have
been
ruled
out.
It
associated
with
several
infectious
pathologies,
states,
and
as
a
known
side
effect
complication
drugs
chemotherapies.
Standard
treatment
calls
for
glucocorticoid-mediated
immunosuppression,
intravenous
immunoglobin
transfusion,
platelet
stimulation,
splenectomy
in
instances
chronic
severe
disease.
While
standard
treatments
are
often
effective,
some
cases
prove
resistant,
more
commonly,
patients
unable
to
tolerate
protocols
or
opt
out
surgical
intervention.
In
addition,
second-line
therapies
can
be
unfeasibly
expensive
effects
themselves.
Therefore,
subset
afflicted
immune
exploration
alternative
methods
needed
order
ease
their
burden
Emerging
evidence
suggests
that
plant-derived
extracts,
traditionally
used
regions
such
Asia
Africa
manage
acute
hold
promise
adjunctive
mentioned
patients.
These
natural
compounds
may
provide
cost-effective
less
invasive
option,
potentially
bridging
gaps
current
regimens.
We
propose
these
extracts
play
role
fulfilling
this
deficiency
protocols.
With
review,
we
aim
characterize
compile
various
organic
utilized
improve
outcomes
By
highlighting
clinical
relevance
potential
integration
into
ITP
protocols,
manuscript
underscores
importance
expanding
patient
reduce
burdens.
Language: Английский